Literature DB >> 31562245

Protein phosphatase 2A controls ongoing DNA replication by binding to and regulating cell division cycle 45 (CDC45).

Abbey L Perl1, Caitlin M O'Connor1, Pengyan Fa2, Franklin Mayca Pozo1, Junran Zhang2, Youwei Zhang1, Goutham Narla3,4.   

Abstract

Genomic replication is a highly regulated process and represents both a potential benefit and liability to rapidly dividing cells; however, the precise post-translational mechanisms regulating genomic replication are incompletely understood. Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase that regulates a diverse array of cellular processes. Here, utilizing both a gain-of-function chemical biology approach and loss-of-function genetic approaches to modulate PP2A activity, we found that PP2A regulates DNA replication. We demonstrate that increased PP2A activity can interrupt ongoing DNA replication, resulting in a prolonged S phase. The impaired replication resulted in a collapse of replication forks, inducing dsDNA breaks, homologous recombination, and a PP2A-dependent replication stress response. Additionally, we show that during replication, PP2A exists in complex with cell division cycle 45 (CDC45) and that increased PP2A activity caused dissociation of CDC45 and polymerase α from the replisome. Furthermore, we found that individuals harboring mutations in the PP2A Aα gene have a higher fraction of genomic alterations, suggesting that PP2A regulates ongoing replication as a mechanism for maintaining genomic integrity. These results reveal a new function for PP2A in regulating ongoing DNA replication and a potential role for PP2A in the intra-S-phase checkpoint.
© 2019 Perl et al.

Entities:  

Keywords:  DNA damage response; DNA replication; DNA-protein interaction; cell cycle; cell cycle checkpoint; cell division cycle 45 (CDC45); genome stability; protein phosphatase 2 (PP2A); replisome; small molecule activator of PP2A (SMAP)

Mesh:

Substances:

Year:  2019        PMID: 31562245      PMCID: PMC6851307          DOI: 10.1074/jbc.RA119.010432

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  43 in total

1.  Protein phosphatase 2A regulates binding of Cdc45 to the prereplication complex.

Authors:  Danny M Chou; Paris Petersen; Johannes C Walter; Gernot Walter
Journal:  J Biol Chem       Date:  2002-08-15       Impact factor: 5.157

Review 2.  Replication-fork dynamics.

Authors:  Karl E Duderstadt; Rodrigo Reyes-Lamothe; Antoine M van Oijen; David J Sherratt
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

Review 3.  Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer.

Authors:  Parthasarathy Seshacharyulu; Poomy Pandey; Kaustubh Datta; Surinder K Batra
Journal:  Cancer Lett       Date:  2013-02-20       Impact factor: 8.679

Review 4.  Replisome components--post-translational modifications and their effects.

Authors:  Juergen Zech; Jacob Zeuthen Dalgaard
Journal:  Semin Cell Dev Biol       Date:  2014-03-28       Impact factor: 7.727

5.  PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells.

Authors:  Otto Kauko; Caitlin M O'Connor; Evgeny Kulesskiy; Jaya Sangodkar; Anna Aakula; Sudeh Izadmehr; Laxman Yetukuri; Bhagwan Yadav; Artur Padzik; Teemu Daniel Laajala; Pekka Haapaniemi; Majid Momeny; Taru Varila; Michael Ohlmeyer; Tero Aittokallio; Krister Wennerberg; Goutham Narla; Jukka Westermarck
Journal:  Sci Transl Med       Date:  2018-07-18       Impact factor: 17.956

6.  Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer.

Authors:  Kimberly McClinch; Rita A Avelar; David Callejas; Sudeh Izadmehr; Danica Wiredja; Abbey Perl; Jaya Sangodkar; David B Kastrinsky; Daniela Schlatzer; Maxwell Cooper; Janna Kiselar; Agnes Stachnik; Shen Yao; Divya Hoon; Daniel McQuaid; Nilesh Zaware; Yixuan Gong; David L Brautigan; Stephen R Plymate; Cynthia C T Sprenger; William K Oh; Alice C Levine; Alexander Kirschenbaum; John P Sfakianos; Rosalie Sears; Analisa DiFeo; Yiannis Ioannou; Michael Ohlmeyer; Goutham Narla; Matthew D Galsky
Journal:  Cancer Res       Date:  2018-01-22       Impact factor: 12.701

Review 7.  SV40 small T antigen and PP2A phosphatase in cell transformation.

Authors:  Anna A Sablina; William C Hahn
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

Review 8.  The S-phase checkpoint: targeting the replication fork.

Authors:  Mónica Segurado; José Antonio Tercero
Journal:  Biol Cell       Date:  2009-08-19       Impact factor: 4.458

Review 9.  Cancer therapy and replication stress: forks on the road to perdition.

Authors:  Panagiotis Kotsantis; Rebecca M Jones; Martin R Higgs; Eva Petermann
Journal:  Adv Clin Chem       Date:  2015-02-07       Impact factor: 5.394

10.  Response to DNA damage: why do we need to focus on protein phosphatases?

Authors:  Midori Shimada; Makoto Nakanishi
Journal:  Front Oncol       Date:  2013-01-31       Impact factor: 6.244

View more
  4 in total

1.  A pan-cancer compendium of chromosomal instability.

Authors:  Geoff Macintyre; Florian Markowetz; Ruben M Drews; Barbara Hernando; Maxime Tarabichi; Kerstin Haase; Tom Lesluyes; Philip S Smith; Lena Morrill Gavarró; Dominique-Laurent Couturier; Lydia Liu; Michael Schneider; James D Brenton; Peter Van Loo
Journal:  Nature       Date:  2022-06-15       Impact factor: 69.504

2.  Targeting Ribonucleotide Reductase Induces Synthetic Lethality in PP2A-Deficient Uterine Serous Carcinoma.

Authors:  Caitlin M O'Connor; Sarah E Taylor; Kathryn M Miller; Lauren Hurst; Terrance J Haanen; Tahra K Suhan; Kaitlin P Zawacki; Fallon K Noto; Jonida Trako; Arathi Mohan; Jaya Sangodkar; Dmitriy Zamarin; Analisa DiFeo; Goutham Narla
Journal:  Cancer Res       Date:  2022-02-15       Impact factor: 13.312

3.  Protein phosphatase 2A (PP2A) promotes anaphase entry after DNA replication stress in budding yeast.

Authors:  Cory Haluska; Fengzhi Jin; Yanchang Wang
Journal:  Mol Biol Cell       Date:  2021-10-20       Impact factor: 4.138

Review 4.  Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents.

Authors:  David L Brautigan; Caroline Farrington; Goutham Narla
Journal:  Clin Sci (Lond)       Date:  2021-07-16       Impact factor: 6.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.